ROMIDEPSIN | A219099 | AMNEAL EU LTD
1 strength0 unique patents0 unique exclusivities
Products (1)
No patent or exclusivity listings for this strength.
ADDED7/1/2026
Amneal received FDA approval for romidepsin (NDA 219099, strength 001), expanding the generic manufacturer's oncology portfolio.